Article Versions Notes

Imamura K, Tomita Y, Sato R, Ikeda T, Iyama S, Jodai T, Takahashi M, Takaki A, Akaike K, Hamada S, et al. Clinical Implications and Molecular Characterization of Drebrin-Positive, Tumor-Infiltrating Exhausted T Cells in Lung Cancer. International Journal of Molecular Sciences. 2022; 23(22):13723. https://doi.org/10.3390/ijms232213723

Imamura, Kosuke, Yusuke Tomita, Ryo Sato, Tokunori Ikeda, Shinji Iyama, Takayuki Jodai, Misako Takahashi, Akira Takaki, Kimitaka Akaike, Shohei Hamada, and et al. 2022. "Clinical Implications and Molecular Characterization of Drebrin-Positive, Tumor-Infiltrating Exhausted T Cells in Lung Cancer" International Journal of Molecular Sciences 23, no. 22: 13723. https://doi.org/10.3390/ijms232213723

Imamura, K., Tomita, Y., Sato, R., Ikeda, T., Iyama, S., Jodai, T., Takahashi, M., Takaki, A., Akaike, K., Hamada, S., Sakata, S., Saruwatari, K., Saeki, S., Ikeda, K., Suzuki, M., & Sakagami, T. (2022). Clinical Implications and Molecular Characterization of Drebrin-Positive, Tumor-Infiltrating Exhausted T Cells in Lung Cancer. International Journal of Molecular Sciences, 23(22), 13723. https://doi.org/10.3390/ijms232213723